Switching From High‐Dose Eculizumab to Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case Report

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 4; no. 4; pp. e455 - n/a
Main Authors Füreder, Wolfgang, Valent, Peter
Format Journal Article
LanguageEnglish
Published Wolters Kluwer Health 01.08.2020
Wiley
Subjects
Case Report
Online AccessGet full text

Cover

More Information
Bibliography:Author contributions: WF and PV analyzed the data and wrote the paper.
PV received honoraria from Alexion, Celgene, Deciphera, Pfizer, Blueprint, Astellas, Incyte and Novartis.
WF received honoraria from Alexion and Novartis.
ISSN:2572-9241
2572-9241
DOI:10.1097/HS9.0000000000000455